http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070117863-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a310cf2440156229ff801fc5b9c9d4f5 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2006-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3db166ec84d31bd194796e152a194c85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f1e071babfdb0193f392e95a0bf9dde http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1a6b122f649db7e64471a77392e302c |
publicationDate | 2007-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20070117863-A |
titleOfInvention | Sensitizers for chemical cancer treatments containing urea compounds as active ingredients |
abstract | The present invention relates to a chemosensitizer comprising a urea compound represented by Formula 1 as an active ingredient. More specifically, the present invention relates to a chemical sensitizer containing, as an active ingredient, a urea compound represented by Formula 1 or a pharmaceutically acceptable salt thereof that exhibits a high chemical sensitizing effect. Since the chemosensitizer according to the present invention can improve the activity of a cancer chemotherapeutic agent, the amount of the cancer chemotherapeutic agent can be reduced, and since side effects are small, it can be usefully used in combination with cancer chemotherapy. |
priorityDate | 2006-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 429.